What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to officially announce and provide access to Boston Scientific's financial results for the second quarter ended June 30, 2014, via an accompanying press release.

Where can I find the detailed financial results for Q2 2014?

The detailed financial results are located in the press release furnished as Exhibit 99.1 to this 8-K filing.

Does this filing contain any new material business developments or executive changes?

No, this 8-K filing is specifically for the purpose of reporting financial results and does not appear to contain information regarding new material business developments or executive changes, which would typically be reported under different 8-K item numbers.

What is the significance of the information not being 'filed' under Section 18 of the Exchange Act?

This means that the company is not subject to the same level of liability under Section 18 of the Securities Exchange Act of 1934 for any inaccuracies or omissions in the furnished information, as it is being provided for informational purposes rather than formally 'filed' with the SEC.

BSX 8-K: Earnings & Results

Summary

Boston Scientific Corporation (BSX) filed an 8-K on July 24, 2014, primarily to report its financial results for the second quarter ended June 30, 2014. The core of this filing is the accompanying press release (Exhibit 99.1), which details the company's performance during the quarter. Investors should review this press release for specific figures on revenue, profitability, and any forward-looking guidance. The 8-K itself serves as the official notification of this information being made public.

Key Highlights

1Boston Scientific announced its second quarter 2014 financial results on July 24, 2014.
2The filing includes a press release (Exhibit 99.1) containing the detailed financial results for the quarter ended June 30, 2014.
3This report is primarily an informational filing to disclose earnings, and investors should refer to the press release for the specific financial figures.
4The information furnished is not deemed 'filed' for the purposes of Section 18 of the Exchange Act, limiting liability for its content under that specific section.
5The filing serves to make the Q2 2014 earnings announcement publicly available through official SEC channels.

BOSTON SCIENTIFIC CORP 8-K Report, Financial Results (Jul 24, 2014)

Summary

Key Highlights

Frequently Asked Questions